{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:40:43Z","timestamp":1772620843724,"version":"3.50.1"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T00:00:00Z","timestamp":1357689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0053992","type":"journal-article","created":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T00:10:42Z","timestamp":1357776642000},"page":"e53992","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":77,"title":["Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model"],"prefix":"10.1371","volume":"8","author":[{"given":"Laura","family":"Ochoa-Callejero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"P\u00e9rez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Rubio-Mediavilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Oteo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 R.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,1,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrgastro.2010.100","article-title":"Hepatocellular carcinoma: A global view","volume":"7","author":"JD Yang","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"HB El-Serag","year":"2011","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/carcin\/bgl060","article-title":"Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa","volume":"27","author":"GD Kirk","year":"2006","journal-title":"Carcinogenesis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jhep.2004.10.005","article-title":"Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma","volume":"42","author":"JA Marrero","year":"2005","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/bjs.7669","article-title":"Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma","volume":"98","author":"L Tiong","year":"2011","journal-title":"Br J Surg"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1745-7254.2007.00688.x","article-title":"Keap1 eye on the target: chemoprevention of liver cancer","volume":"28","author":"MS Yates","year":"2007","journal-title":"Acta Pharmacol Sin"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000315246","article-title":"Positioning and indication of sorafenib in the treatment algorithm and real practice setting: Western and eastern approach\u2013Asian perspective","volume":"78","author":"JM Lee","year":"2010","journal-title":"Oncology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pop.2011.05.005","article-title":"Care of chronic liver disease","volume":"38","author":"D Jiang","year":"2011","journal-title":"Prim Care"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"R Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1055\/s-2001-17554","article-title":"Cytokine receptors and signaling in hepatic stellate cells","volume":"21","author":"M Pinzani","year":"2001","journal-title":"Semin Liver Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"SL Friedman","year":"2008","journal-title":"Physiol Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.1074\/jbc.M010303200","article-title":"Signal transduction by the chemokine receptor CXCR3: activation of Ras\/ERK, Src, and phosphatidylinositol 3-kinase\/Akt controls cell migration and proliferation in human vascular pericytes","volume":"276","author":"A Bonacchi","year":"2001","journal-title":"J Biol Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"G949","DOI":"10.1152\/ajpgi.00215.2003","article-title":"Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration","volume":"285","author":"RF Schwabe","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/hep.22890","article-title":"Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation","volume":"49","author":"F Hong","year":"2009","journal-title":"Hepatology"},{"key":"ref15","first-page":"1858","article-title":"CCR1 and CCR5 promote hepatic fibrosis in mice","volume":"119","author":"E Seki","year":"2009","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jhep.2011.04.023","article-title":"RANTES antagonism: a promising approach to treat chronic liver diseases","volume":"55","author":"S Affo","year":"2011","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.gastro.2004.09.010","article-title":"Introduction: The burden of hepatocellular carcinoma","volume":"127","author":"LB Seeff","year":"2004","journal-title":"Gastroenterology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1172\/JCI41732","article-title":"Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice","volume":"120","author":"ML Berres","year":"2010","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.17.1.657","article-title":"Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease","volume":"17","author":"EA Berger","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1128\/AAC.49.11.4721-4732.2005","article-title":"Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity","volume":"49","author":"P Dorr","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm1319","article-title":"Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1","volume":"11","author":"G Fatkenheuer","year":"2005","journal-title":"Nat Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1517\/17425255.2010.510833","article-title":"Vicriviroc, a new CC-chemokine receptor 5 inhibitor for treatment of HIV: properties, promises and challenges","volume":"6","author":"JC Lenz","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/QAI.0b013e318213c2c0","article-title":"Safety, efficacy, and pharmacokinetics of TBR-652, a CCR5\/CCR2 antagonist, in HIV-1-infected, treatment-experienced, CCR5 antagonist-naive subjects","volume":"57","author":"J Lalezari","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/jpet.111.179531","article-title":"Identification and characterization of INCB9471, an allosteric noncompetitive small-molecule antagonist of C-C chemokine receptor 5 with potent inhibitory activity against monocyte migration and HIV-1 infection","volume":"338","author":"N Shin","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/AAC.00821-07","article-title":"Hepatotoxicity observed in clinical trials of aplaviroc (GW873140)","volume":"52","author":"WG Nichols","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1016\/j.bmcl.2010.06.003","article-title":"Anibamine, a natural product CCR5 antagonist, as a novel lead for the development of anti-prostate cancer agents","volume":"20","author":"X Zhang","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s10096-012-1546-5","article-title":"Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV\/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapy","volume":"31","author":"J Macias","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/carcin\/bgi365","article-title":"Hepatic oval cell response to the choline-deficient, ethionine supplemented model of murine liver injury is attenuated by the administration of a cyclo-oxygenase 2 inhibitor","volume":"27","author":"RA Davies","year":"2006","journal-title":"Carcinogenesis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1053\/j.gastro.2008.05.077","article-title":"C-kit inhibition by imatinib mesylate attenuates progenitor cell expansion and inhibits liver tumor formation in mice","volume":"135","author":"B Knight","year":"2008","journal-title":"Gastroenterology"},{"key":"ref30","first-page":"5042","article-title":"High incidence of hepatocellular carcinomas induced by a choline deficient L-amino acid defined diet in rats","volume":"52","author":"D Nakae","year":"1992","journal-title":"Cancer Res"},{"key":"ref31","first-page":"1092","article-title":"Early histological and functional alterations of ethionine liver carcinogenesis in rats fed a choline-deficient diet","volume":"38","author":"H Shinozuka","year":"1978","journal-title":"Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/clinchem\/46.12.2027","article-title":"Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests","volume":"46","author":"DR Dufour","year":"2000","journal-title":"Clin Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jcp.10112","article-title":"p38 MAP kinase mediates platelet-derived growth factor-stimulated migration of hepatic myofibroblasts","volume":"191","author":"P Tangkijvanich","year":"2002","journal-title":"J Cell Physiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1586\/eri.11.52","article-title":"Lessons from maraviroc clinical trials","volume":"9","author":"P Troia-Cancio","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2165\/11590700-000000000-00000","article-title":"Clinical utility of maraviroc","volume":"31","author":"J Parra","year":"2011","journal-title":"Clin Drug Investig"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1440-1711.2005.01346.x","article-title":"Liver inflammation and cytokine production, but not acute phase protein synthesis, accompany the adult liver progenitor (oval) cell response to chronic liver injury","volume":"83","author":"B Knight","year":"2005","journal-title":"Immunol Cell Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/jhep.2001.26751","article-title":"A modified choline-deficient, ethionine-supplemented diet protocol effectively induces oval cells in mouse liver","volume":"34","author":"B Akhurst","year":"2001","journal-title":"Hepatology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/hep.22597","article-title":"Lymphotoxin-beta receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury","volume":"49","author":"RG Ruddell","year":"2009","journal-title":"Hepatology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/j.1478-3231.2008.01825.x","article-title":"Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition","volume":"28","author":"G Svegliati-Baroni","year":"2008","journal-title":"Liver Int"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1189\/jlb.0506297","article-title":"The role of cytokines in hepatocellular carcinoma","volume":"80","author":"A Budhu","year":"2006","journal-title":"J Leukoc Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0030-1255351","article-title":"Chemokines in liver inflammation and fibrosis","volume":"30","author":"HE Wasmuth","year":"2010","journal-title":"Semin Liver Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/gutjnl-2011-300509","article-title":"Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma","volume":"61","author":"V Chew","year":"2011","journal-title":"Gut"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jcp.21783","article-title":"CCL5\/CCR5 axis promotes the motility of human oral cancer cells","volume":"220","author":"JY Chuang","year":"2009","journal-title":"J Cell Physiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1478-3231.2009.01992.x","article-title":"Expression of extracellular matrix genes in cultured hepatic oval cells: an origin of hepatic stellate cells through transforming growth factor beta?","volume":"29","author":"P Wang","year":"2009","journal-title":"Liver Int"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4161\/cbt.8.18.9843","article-title":"Cancer stem cells and hepatocellular carcinoma","volume":"8","author":"Z Yao","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/toxsci\/65.2.166","article-title":"Mechanisms of hepatotoxicity","volume":"65","author":"H Jaeschke","year":"2002","journal-title":"Toxicol Sci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1128\/JVI.02594-09","article-title":"Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen","volume":"84","author":"DM Iser","year":"2010","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0002-9440(10)63921-1","article-title":"Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas","volume":"162","author":"P Lu","year":"2003","journal-title":"Am J Pathol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1158\/0008-5472.CAN-04-2616","article-title":"C-C chemokine receptor 5 on stromal cells promotes pulmonary metastasis","volume":"65","author":"HW van Deventer","year":"2005","journal-title":"Cancer Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.4049\/jimmunol.181.9.6384","article-title":"CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process","volume":"181","author":"Y Wu","year":"2008","journal-title":"J Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e15257","DOI":"10.1371\/journal.pone.0015257","article-title":"Oral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model","volume":"5","author":"CP Neff","year":"2010","journal-title":"PLoS One"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"H1153","DOI":"10.1152\/ajpheart.00886.2010","article-title":"Liver growth factor treatment restores cell-extracellular matrix balance in resistance arteries and improves left ventricular hypertrophy in SHR","volume":"301","author":"MV Conde","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2144\/01311dd03","article-title":"Array-based ELISAs for high-throughput analysis of human cytokines","volume":"31","author":"MD Moody","year":"2001","journal-title":"Biotechniques"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0053992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T04:09:03Z","timestamp":1595218143000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0053992"}},"subtitle":[],"editor":[{"given":"Yujin","family":"Hoshida","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,9]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0053992","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,9]]}}}